Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares

NCT01120340 is registered in ClinicalTrials.gov with SOFAR S.p.A. as lead sponsor.

NCT NCT01120340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01120340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares
Lead sponsor
SOFAR S.p.A.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
November 30, 2011
Enrollment
105 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diverticular disease